🔎 Trials Near Me

Akèy › Kansè trakt bilè › Texas › Dallas

Etid klinik pou Kansè trakt bilè nan Dallas, TX

6 etid pou Kansè trakt bilè ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center (Site 104), Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07265674

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Ap rekriteFaz 1/2
  • Avenzo Therapeutics Recruiting Site, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07038343

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Ap rekriteFaz 3
  • Research Site, Dallas
Laj 18 a 99 · Tout sèks · Mizajou Aug 19, 2026 · NCT06467357

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Ap rekriteFaz 1/2
  • Texas Oncology, P.A., Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Ap rekriteFaz 2
  • Baylor Scott & White Research Institute, Dallas
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Ap rekriteFaz 2
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT06789848

Etid Kansè trakt bilè nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.